Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply Side
1 other identifier
interventional
336
1 country
2
Brief Summary
The goal of this clinical trial is to determine whether integration of vision care into the DM treatment system, by providing specific recommendations to doctors for management of diabetes alongside feedback on positive eye exams for DR can improve diabetes care outcomes. The main questions it aims to answer are:
- 1.Does delivery of specific diabetes management recommendations to diabetes doctors for patients of theirs found to have DR lead to significantly improved blood glucose control as indicated by % reaching WHO targets of HbA1c (or targets for blood sugar if HbA1c data are unavailable)?
- 2.What is the cost-effectiveness of the intervention, measured as total intervention cost per additional participant reaching the WHO target?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
Started Aug 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedStudy Start
First participant enrolled
August 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
September 11, 2025
September 1, 2025
1.3 years
May 5, 2025
September 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The proportion of participants reaching WHO target HbA1c levels of <= 7.0% (or WHO blood sugar targets if HbA1c data are unavailable) among participants with any DR, upon chart review by a masked clinician observer, compared between study groups.
According to the World Health Organization (WHO), the specific HgA1c target is \<= 7.0%
From enrollment to chart review (3 months after enrollment)
Secondary Outcomes (1)
Cost-effectiveness, measured as total intervention cost per additional patient meeting the WHO blood sugar target.
Enrollment to chart review (3 months after enrollment)
Study Arms (2)
Control Group: Only DR results provided
NO INTERVENTIONFor these participants, the patient information system (PIS) will send only diabetic retinopathy (DR) results to the Diabetologist at the diabetic hospital without specific care recommendations
Intervention Group: DR results + care recommendations for DM management provided
EXPERIMENTALFor these participants, the patient information system (PIS) will send DR results to the Diabetologist at the diabetic hospital along with specific care recommendations for diabetes management (only for those patients with ANY DR)
Interventions
Provision of specific care recommendations for diabetes management. Based on existing guidelines, when any DR is present, the PIS will prompt diabetologists to check, and if necessary, change medicines to optimize, blood sugar, blood pressure and lipids.
Eligibility Criteria
You may qualify if:
- Diagnosed with DM
- Diagnosed with DR in at least one eye
- Over 30 years of age
- Currently treated at the Dinajpur Diabetes Hospital and Gausul Azam BNSB Eye Hospital in Bangladesh
- willingness to participate in the study
You may not qualify if:
- Any ocular condition impairing the view of the fundus sufficiently to preclude grading of the image for DR.
- Inability to comply with retinal photography to the extent that a gradable image cannot be captured, or any other factor leading to absence of sufficient images to grade at least one eye of a participant.
- Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
- Unwilling to participate in the study, or incapable of giving informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dinajpur Diabetes & Swasthoseba Hospital
Dinajpur Sadar, Dinajpur, 5200, Bangladesh
Gausul Azam BNSB Eye Hospital
Dinajpur District, Bangladesh
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Munir Ahmed
Orbis Bangladesh
- PRINCIPAL INVESTIGATOR
Nathan Congdon
Orbis
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2025
First Posted
May 13, 2025
Study Start
August 25, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
September 11, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
de-identified data will be shared upon reasonable request to the corresponding author